DONOR ORGANS PHARMACOLOGICAL PROTECTION

Pancreas and kidney transplantation using embryonic donor organs.

One novel solution to the shortage of human organs available for transplantation envisions 'growing' new organs in situ. This can be accomplished by transplantation of developing organ anlagen/primordia. We and others have shown that renal anlagen (metanephroi) transplanted into animal hosts undergo differentiation and growth, become vascularized by blood vessels of host origin and exhibit excr...

Maximizing the utilization of donor organs offered for lung transplantation.

The number of patients awaiting lung transplantation (LT) and waiting time for surgery is increasing. In Australia, LT rates are 4. 6/million population/yr, which despite low organ donation rates, are the highest published in the world. The Australian organ allocation system allows identification of marginal donors and therapeutic manipulation where appropriate. This study aims to assess the im...

A new law for allocation of donor organs in Israel.

Israel’s system for organ donation has been based, since its inception in 1968, on a model in which organs for transplantation are retrieved from brain-dead donors only after consent has been obtained from the appropriate fi rst-degree relatives. This consent is needed even if the potential donor has expressed a wish for posthumous organ donation by signing a donor card, which is a government f...

The Ethics of Donation and Donor Protection

Usefulness of nanoparticles to making shield and protection of sensitive organs in chest CT scan test

Introduction: Recently, the use of nanoparticles has increased for many purpose in medicine. One of these is using the nano particles in shields structure to protect sensitive organs such as breast which placed inside the field of chest CT scan and receives high dose. The aim of this study was the use of nano Bi2O3 to making shield for protection breast in chest CT examination ...